Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh
RIGHT
1 other identifier
interventional
75
0 countries
N/A
Brief Summary
A dietary intervention study designed as a randomized, controlled, parallel intervention of 6-weeks duration. A total of 75 participants will be included in the study and randomly allocated to one of three interventions (refined wheat, whoelgrain wheat or wholegrain rye). Clinincal examinations including anthropometric assessment, fecal, urine and fastign blood sampling, dietary assessment and a meal challenge will be done before (week 0) and after (week 6) the intervention. At timepoints week 0, 2, 4 and 6 questionnaires will be filled in concerning satisfaction with diet and gastrointestinal symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 21, 2015
CompletedFirst Posted
Study publicly available on registry
February 6, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 6, 2015
February 1, 2015
3 months
January 21, 2015
February 3, 2015
Conditions
Outcome Measures
Primary Outcomes (2)
Gastrointestinal symptoms evaluated by questionnaires (100mm visual analogue scales)
Subjective sensations of gastrointestinal symptoms evaluated by questionnaires (100mm visual analogue scales)
Change from 0 to 6 weeks
Gut microbiota composition assessed using 16S in a single fecal sample
Gut microbiota compostion assessed using 16S in a single fecal sample
Change from 0 to 6 weeks
Secondary Outcomes (13)
Anthropometric masures
Change from 0 to 6 weeks
Blood pressure
Change from 0 to 6 weeks
Blood lipids, fasting concentrations of total, LDL and HDL cholesterol and triglyerides
Change from 0 to 6 weeks
Glucose metabolism, fasting concentrations of glucose, insulin and HbA1C as calculation of HOMA-IR
Change from 0 to 6 weeks
Low-grade inflammation, fasting concentrations of hsCRP, IL-6, IL-10, and TNF-a
Change from 0 to 6 weeks
- +8 more secondary outcomes
Study Arms (3)
Refined wheat
ACTIVE COMPARATORRefined wheat grain, a variety of cereal foods providing no wholegrain
Wholegrain wheat
EXPERIMENTALWholegrain wheat grain, a variety of cereal foods providing \>100g wheat wholegrain/day
Wholegrain rye
EXPERIMENTALWholegrain rye grain, a variety of cereal foods providing \>100g rye wholegrain/day
Interventions
A variety of cereal foods providing \>100g/day wholegrain from wheat
Eligibility Criteria
You may qualify if:
- Age: 30 - 65 years
- Body mass index (BMI): 25 - 32 kg/m2
- Weight stable (\<3 kg weight change during the last 6 months)
- Apparently healthy
- Informed consent signed
- Freezer capacity for 2 weeks bread provision
- Can attend all visits required for the study
You may not qualify if:
- Smoking on a daily basis
- Lactating (or lactating within 6 weeks prior to study start), pregnant (or pregnant within 3 months prior to study start) or wish to become pregnant during the study
- Diagnosed with any form of diabetes or CVD
- Reported chronic GI disorders
- Antibiotic treatment 3 month before study start and during the study
- Use of pre- or probiotic 1 month before study start and during the study
- Lack of cooperation and adherence to the protocol
- Use of prescription medication will be evaluated on an individual basis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Copenhagenlead
- Lantmännens Forskningsstiftelsecollaborator
Related Publications (3)
Christensen L, Vuholm S, Roager HM, Nielsen DS, Krych L, Kristensen M, Astrup A, Hjorth MF. Prevotella Abundance Predicts Weight Loss Success in Healthy, Overweight Adults Consuming a Whole-Grain Diet Ad Libitum: A Post Hoc Analysis of a 6-Wk Randomized Controlled Trial. J Nutr. 2019 Dec 1;149(12):2174-2181. doi: 10.1093/jn/nxz198.
PMID: 31504699DERIVEDVuholm S, Nielsen DS, Iversen KN, Suhr J, Westermann P, Krych L, Andersen JR, Kristensen M. Whole-Grain Rye and Wheat Affect Some Markers of Gut Health without Altering the Fecal Microbiota in Healthy Overweight Adults: A 6-Week Randomized Trial. J Nutr. 2017 Nov;147(11):2067-2075. doi: 10.3945/jn.117.250647. Epub 2017 Sep 27.
PMID: 28954842DERIVEDSuhr J, Vuholm S, Iversen KN, Landberg R, Kristensen M. Wholegrain rye, but not wholegrain wheat, lowers body weight and fat mass compared with refined wheat: a 6-week randomized study. Eur J Clin Nutr. 2017 Aug;71(8):959-967. doi: 10.1038/ejcn.2017.12. Epub 2017 Mar 22.
PMID: 28327566DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 21, 2015
First Posted
February 6, 2015
Study Start
September 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2015
Last Updated
February 6, 2015
Record last verified: 2015-02